Certican 0.75 mg Tablet
$27.09
$23.80
Certican 0.75 mg Tablet is a targeted anticancer therapy indicated for the treatment of various advanced malignancies, including cancers of the pancreas, stomach, intestines, and lungs, particularly when surgical options are no longer viable. This medication is also effective for postmenopausal women battling advanced hormone receptor-positive breast cancer that is HER2-negative. In addition, Certican is utilized in adult patients with progressive kidney cancer following unsuccessful treatment with sunitinib or sorafenib. The active ingredient works by inhibiting specific pathways that allow cancer cells to proliferate, thereby slowing down disease progression. It is crucial to be aware of potential side effects, including increased risk of infection and liver enzyme alterations, which necessitate regular monitoring during treatment. Patients should discuss their full medical history with their healthcare provider to ensure safe use of Certican. This medication is best used as part of a comprehensive cancer management plan tailored to individual patient needs. Always consult your healthcare professional for personalized advice and guidance when considering Certican as part of your cancer treatment regimen.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Certican 0 75 mg tablet is primarily indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women. This medication is often used in conjunction with exemestane after previous treatments with letrozole or anastrozole have proven ineffective. By targeting specific pathways, Certican helps to slow the progression of cancer. Patients may benefit from this combination approach, especially when facing advanced stages of the disease.
• The use of Certican 0 75 mg tablet can be essential for managing symptoms associated with advanced breast cancer. Patients often experience various symptoms, such as changes in breast size or shape, which can impact their quality of life. By utilizing Certican, healthcare providers aim to alleviate some of these symptoms while addressing the underlying cancer. This dual focus on symptom management and disease control is a key aspect of treatment.
• Certican 0 75 mg tablet is also beneficial for women who have experienced treatment failure with other hormonal therapies. After the ineffectiveness of letrozole or anastrozole, transitioning to Certican combined with exemestane can offer a new therapeutic option. This adaptability in treatment regimens is crucial for optimizing patient outcomes. The strategic use of Certican allows for continued management of the disease in challenging cases.
• In addition to its role in cancer treatment, Certican 0 75 mg tablet can support patients' overall treatment plans by providing an additional line of defense against disease progression. This medication is part of a comprehensive approach that may include lifestyle changes and supportive care. By incorporating Certican, clinicians can enhance therapeutic strategies tailored to individual patient needs. Ultimately, this contributes to a more holistic management of breast cancer in postmenopausal women.
Benefits
Certican 0.75 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Certican 0.75 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Certican 0.75 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
Certican 0.75 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Certican 0.75 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Certican 0.75 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Certican 0.75 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Certican 0.75 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Certican 0.75 mg. Certican 0.75 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Certican 0.75 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Certican 0.75 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Certican 0.75 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Certican 0.75 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Certican 0.75 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Certican 0.75 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Certican 0.75 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Certican 0.75 mg.